Total Funding
42
Total FundingGrant raised
Growth Score in past quarter
pts
Heat Score 42 in past quarter
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
157521
Nervive is a for-profit C-corp that is developing the VitalFlow, an emergency treatment for stroke and traumatic brain injury.
Stephanie Harrington: Chief Clinical and Regulatory OfficerPast Role: Merlot OrthopediX, Chief Operating Officer
Emilio Sacristan: Founder and CEOPast Role: Nervive, Chief Science Officer
About the Company
Nervive is a stock-based Delaware C-corp that develops a new treatment for brain ischemia. Its primary product, VitalFlow Stimulator, is non-invasive platform technology that treats conditions of brain ischemia such as cerebral artery vasospasm, ischemic stroke, and traumatic brain injury.
Founded in 2013, Nervive is headquartered in Akron, Ohio.
